Initial Clinical Characteristics of 146 Patients with COVID-19 Reported in Guizhou Province, China: A Survival Analysis.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
31 01 2022
Historique:
received: 11 03 2021
accepted: 03 08 2021
entrez: 22 2 2022
pubmed: 23 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Coronavirus disease 2019 (COVID-19) has caused an outbreak around the world. Early detection of severe illness is crucial for patients' survival. We analysed initial clinical characteristics of 146 patients with COVID-19 reported in Guizhou province, China to explore risk factors for transforming mild illness to severe. Data of 146 laboratory-confirmed cases were collected and evaluated by the survival analysis of univariate and multivariate Cox proportional hazards model. On initial presentation, patients had fever (51.05%), dry cough (45.45%), headache (16.08%), shortness of breath (7.75%) and gastrointestinal symptoms (13.99%). Among 146 laboratory-confirmed cases, 30 patients (20.55%) had severe illness and needed Intensive Care Unit care for supportive treatment. The remaining patients (116, 79.45%) were non-severe cases. Nineteen (19/146, 13.01%) of 30 patients in the Intensive Care Unit had comorbidities, including hypertension (12, 40.00%), diabetes (5, 16.67%), cardiovascular disease (5, 16.67%) and pulmonary disease (4, 13.33%). For survival analysis, patients who had fever (HR = 3.30, 95% CI = 1.31, 8.29) and comorbidities (HR = 9.76, 95% CI = 4.28, 22.23) at baseline were more likely to be admitted into the Intensive Care Unit. Few variables were not related to the survival time of discharge from baseline to discharge and from Intensive Care Unit care to discharge. Severe patients with COVID-19 should be paid more attention. On initial symptoms, many patients did not have fever, but those with fever were more likely to be admitted to the Intensive Care Unit. Comorbidities were likewise a risk factor of severe COVID-19.

Identifiants

pubmed: 35192519
doi: 10.3855/jidc.15027
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-40

Informations de copyright

Copyright (c) 2022 Yun Gou, Kaike Ping, Mingyu Lei, Chun Yu, Ying Tao, Can Hu, Zhongfa Tao, Zhiting Zou, Weijia Jiang, Shijun Li, Li Zhuang, Zhaobin Liu, Yan Huang.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Yun Gou (Y)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China. 499545438@qq.com.

Kaike Ping (K)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Mingyu Lei (M)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Chun Yu (C)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Ying Tao (Y)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Can Hu (C)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Zhongfa Tao (Z)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Zhiting Zou (Z)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Weijia Jiang (W)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Shijun Li (S)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Li Zhuang (L)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Zhaobin Liu (Z)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Yan Huang (Y)

Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH